A carregar...
Recent advances and new opportunities for targeting human dendritic cells in situ
Targeting antigens directly to dendritic cells (DCs) in situ has emerged as a promising strategy to potentiate immunity. A recent clinical trial of antibody-mediated targeting of tumor antigen NY-ESO1 to the DC receptor DEC-205 demonstrated an induction of strong cellular and humoral responses. Rece...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292727/ https://ncbi.nlm.nih.gov/pubmed/25610750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954832 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|